Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Induction of apoptosis and transient increase of phosphorylated MAPKs by diallyl disulfide treatment in human nasopharyngeal carcinoma CNE2 cells — Yi Wei Zhang (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Induction of apoptosis and transient increase of phosphorylated MAPKs by diallyl disulfide treatment in human nasopharyngeal carcinoma CNE2 cells
Shared by
Jianbo Xiao
Universidade de Vigo
Induction of apoptosis and transient increase of phosphorylated MAPKs by diallyl disulfide treatment in human nasopharyngeal carcinoma CNE2 cells
Article
2006
en
Authors
+3 more
YZ
Yi Wei Zhang
JW
Jun Wen
Jianbo Xiao
Universidade de Vigo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2008
Mitogen-activated Protein Kinase Inhibitors Induce Apoptosis and Enhance the Diallyl Disulfide-induced Apoptotic Effect in Human CNE2 Cells
Jun Wen
,
Xiao Chun Wang
,
Yi Wei Zhang
,
Ya Li Nie
,
Simon G. Talbot
,
Gloria C. Li
,
Jianbo Xiao
,
Ming Xu
Article
2008
Comparative effects of natural and synthetic diallyl disulfide on apoptosis of human breast‐cancer MCF‐7 cells
Zou Jun
,
Makiko Suzuki
,
Jianbo Xiao
,
Jun Wen
,
Simon G. Talbot
,
Gloria C. Li
,
Ming Xu
Article
2001
Induction of Apoptosis by Cidofovir in Human Papillomavirus (HPV)-Positive Cells
Graciela Andreï
,
Robert Snoeck
,
Dominique Schols
,
De Clercq Erik
Article
2022
Cytotoxicity and Apoptosis Induction of 6,7-Dehydroroyleanone from Taiwania cryptomerioides Bark Essential Oil in Hepatocellular Carcinoma Cells
Guanrong Chen
,
Mei‐Ling Chang
,
Shang‐Tzen Chang
,
Yu-Tung Ho
,
Hui-Ting Chang
Pharmaceutics
Article
2012
Abstract 3115: PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors
Judith Michels
,
Ilio Vitale
,
Lorenzo Galluzzi
,
Oliver Kepp
,
Laura Senovilla
,
Ken A. Olaussen
,
Jean‐Charles Soria
,
Maria Castedo
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.